as strong clonality, self-renewal and pluripotency, and they could be induced to differentiate, under different induction conditions, into various tissues such as nervous, bone, muscle and adipose tissues. [11] [12] [13] [14] For example, according to a previous study, PDLSCs could differentiate into fibroblasts, osteoblast-like cells and cementum cell-like cells to generate natural periodontium-like connective tissue, osteoid tissue and cementoid tissue. The spatial arrangement and morphological structure of these tissues mentioned above resembled the natural periodontal ligament and cementum complex. 14 In addition, unlike bone mesenchymal stem cells (BMSCs), PDLSCs can be obtained via a simple, minimally invasive procedure and have low immunogenicity. 15, 16 Consequently, PDLSCs are regarded as essential and perfect seeding cells in the fields of bone regeneration, especially for the reconstruction of the alveolar bone defect.
Since the structure DNA nanotechnology was put forward by Seeman in 1982, DNA nanomaterials have both aroused wide public concern and become a research hotspot in related fields because of their programmability, controllability and good mechanical performance. [17] [18] [19] There are various DNA nanomaterial structures, such as one-dimensional DNA structures including linear DNA, two-dimensional DNA structures, which self-assemble to form planar structures such as a triangle, a pentagram and three-dimensional DNA structures, including octahedron and dodecahedron. [20] [21] [22] [23] [24] However, one of the simplest and strongest three-dimensional structural models, the tetrahedral DNA nanostructure (TDN) self-assembled by four specific single-stranded DNA (ssDNA) by complementary base pairing, has received the most extensive attention and application among all DNA structures. Therefore, TDN has great potential for application in molecular diagnosis, drug delivery and bioimaging. In addition, because of the merits of excellent biocompatibility, high stability, low toxicity, fast degradation and direct cellular uptake through endocytosis without carriers, TDNs have been applied to tissue engineering in order to modulate the biological behaviours of stem cells, including proliferation, migration and differentiation. 25 Therefore, PDLSCs were exposed to TDNs, with the purpose of systematically exploring the role of TDNs in the proliferation and osteogenic differentiation of PDLSCs. The results indicated that TDNs had a tremendous potential for application in PDLSC-based bone regeneration.
| MATERIAL S AND ME THODS

| Materials
As shown in Table 1 , well-defined ssDNAs were synthesized by TAKARA (Dalian, China). LPS and alkaline phosphatase (ALP) assay kit, which were used to induce the inflammatory environment, were obtained from Beyotime (Shanghai, China). Osteogenic differentiation medium was purchased from Cyagen (Shanghai, China). Primary antibodies and secondary antibodies were purchased separately from Abcam (Cambridge, UK) and Signalway Antibody (Shanghai, China).
| Synthesis and characterization of TDNs
Tetrahedral DNA nanostructures were prepared as reported previously with four pre-designed DNA single strands. 33, 34 In brief, these four DNA single strands at the same ratio were mixed into the TM buffer (10 mmol/L Tris-HCl, 50 mmol/L MgCl 2 , pH 8.0), and the mixture was heated at 95°C for 10 minutes and then incubated at 4°C for 20 minutes. The successful synthesis of TDNs needed to be corroborated using polyacrylamide gel electrophoresis (PAGE; 8%). In addition, the configuration of TDNs was displayed by using atomic force microscopy (AFM) and transmission electron microscope (TEM).
| Sample collection and PDLSC culture
The periodontal ligament tissue samples came from the extracted third molars, healthy and with no inflammation, of adults between 18 and 25 years old. We received the informed consent of the donors, and we followed the guidelines of the ethics committee of the University of Sichuan. The isolation and culture of cells have been described in previous studies. 14 concentration of TDNs. The PDLSCs were placed into a 16-well plate with 5000 cells per well. After cultured with regular growth medium for 24 hours, these cells were exposed to the TDNs solutions with concentrations of 0, 125, 250 and 375 nmol/L. Then we used the CCK-8 and RTCA to monitor cell proliferation for 24-48 hours and choose the optimum effect concentration on the PDLSCs.
| Cell proliferation assay
| Flow cytometry
We used RTCA and CCK8 to analyse the effect of TDNs on PDLSC proliferation. Besides that, we also applied a cell cycle detection kit (KeyGen Biotech, Nanjing, China) to explore the effect on the cell cycle of PDLSCs. After TDN exposure for 24 hours, the PDLSCs were trypsinized by 0.25% trypsin and centrifuged at 10 300 g for 5 minutes. We dislodged the supernatant lightly and added the ice-cold 70% ethyl alcohol to fix the PDLSCs overnight. The samples washed with PBS were mixed with RNase A and dyed with PI.
A flow cytometer (guava easyCyte; Millipore, Billerica, MA, USA) was applied to detect the DNA contents. Finally, two computer software packages, WinMDI2.9 and WinCycle, were employed to analyse the results.
| TDN Treatment to promote osteogenic differentiation of PDLSCs
When PDLSCs were fused to 85%, the cells were seeded with the (0.05 mmol/L), 10% FBS, β-glycerophosphate (10 mmol/L), dexamethasone (100 nmol/L) and α-MEM medium. Then the PDLSCs were exposed to the 250 nmol/L TDNs solution to promote the osteogenic differentiation, while the same volume of TM buffer was put into the control groups. The induction time would last for 3 and 7 days, and the medium should be replaced every 3-4 days.
| ALP staining
After the PDLSCs were treated with TDNs for 7 days, a BCIP/NBT ALP colour development kit (Beyotime, Shanghai, China) was applied to observe the roles played by TDNs in the osteogenic differentiation of PDLSCs. The cells were rinsed with PBS thrice to clean up residual medium. Then 4% cold paraformaldehyde was employed to fix the PDLSCs samples for 20 minutes. After washed thrice again with PBS, the cells were stained with ALP colour buffer solution for about 2 hours at 37°C until the colour of the samples became dark blue. Rinsed by PBS, the PDLSCs samples were observed with a fluorescent microscope.
| Calcium deposition assay
The PDLSCs exposed to 250 nmol/L TDNs for 2 weeks as previously described, the calcium deposition that was considered as a late marker of the PDLSCs osteogenic differentiation was detected with Alizarin Red staining. Washed with PBS, the PDLSCs were fixed by 4% cold paraformaldehyde for 20 minutes. After that, the Alizarin Red S dye liquor (Sigma, St. Louis, MO, USA) was applied to dye the samples for a half hour at room temperature and a fluorescent microscope was used to survey the calcium deposition.
| Quantitative reverse transcription (RT)-PCR
For the sake of evaluating, the expression of inflammatory and osteogenic genes, such as runt-related transcription factor 2 (RUNX 2), ALP, osteopontin (OPN), quantitative RT-PCR, was employed.
( Table 2 , and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was characterized as the housekeeping gene.
| WB
Exposed to 250 nmol/L TDNs for 1, 3 and 7 days, respectively, the PDLSCs samples were rinsed with PBS softly. The cell protein extraction reagent (KeyGen Biotech) was used to harvest the total proteins. In order to make these collected proteins denature and 
| Immunofluorescence staining
| Statistical analysis
The result comparisons between experimental groups and control groups were obtained using the student's t test. The SPSS 19.0 software (IBM, Armonk, NY, USA) was applied to make statistical analysis for all the experiment data, when P values <0.05, they were statistically significant. All experiments were repeated at least three times.
| RE SULTS
| Characterization of TDNs
In Figure 1A , A synthesis diagram shows the tetrahedral structure of TDNs formed by self-folding of four pre-synthesized ssDNA based on complementary base pairing. 25 An 8% PAGE was performed in order to demonstrate that the tetrahedral DNA nanostructure was successfully synthesized ( Figure 1B ). Furthermore, we used AFM to explore the shape of TDNs, which displayed that it had a triangular particle, diverse in size, about 2-3 nm in width and about 17 nm in height ( Figure 1C ). 35 Figure 1D shows a TEM image that presents the configuration of TDNs, too. In addition, we performed immunofluorescence staining to detect the red fluorescence of CY5 tagged to S1, which proved that TDNs could enter the PDLSCs without the carrier, but a single strand of DNA could not ( Figure 1E ,F).
| Effect of TDNs on proliferation
For the sake of exploring the influence of TDNs and choosing the optimum effective concentration for PDLSCs, a RTCA was performed. As shown in Figure 2A , TDNs were added as indicated by the yellow arrow. After 48 hours, the PDLSC proliferation in the experimental groups treated with TDNs was significantly higher than in the control group; when the concentration of TDNs reached 250 nmol/L, the proliferation of PDLSCs was evident (Figure 2A,B ). Furthermore, we used a Cell Counting Kit-8 to confirm the validity of the results shown above. The results of the CCK8 assay were consistent with the results of the RTCA, which demonstrated that TDNs had a significant effect on the proliferation of PDLSCs, and the optimum effect concentration was indeed 250 nmol/L ( Figure 2C ).
| Effect of TDNs on cell cycle of PDLSCs
We used flow cytometry to explore the role of TDNs on the PDLSCs by detecting cell cycle changes. After PDLSCs were exposed to 250 nmol/L TDNs for one day, there was a significant difference 
| Effect of TDNs on the expression of osteogenesis-related genes and albumen in PDLSCs
As typical osteogenic-related markers, OPN, RUNX2 and ALP were chosen to demonstrate that TDNs could facilitate the osteogenic differentiation of PDLSCs at the gene and protein levels. 36, 37 Exposed to 250 nmol/L TDNs for 3 and 7 days, the gene samples of PDLSCs were analysed by RT-PCR to characterize the part played by TDNs in the osteogenic differentiation of PDLSCs at the gene level.
Quantitative analysis results were obtained by RT-PCR ( Figure 3A) .
The results showed the same tendency as the qualitative analysis, which manifested that TDNs had a positive effect on the osteogenicspecific gene expression in PDLSCs.
After the gene evaluation, WB and immunofluorescence were performed to detect the albumen contents of OPN and RUNX2 regarded as osteogenic-related markers. Following TDN treatment for 3 and 7 days, it can be seen in Figure 3C that the albumen contents of the TDN-treated groups were up-regulated notably. Figure 3D shows the quantitative statistical summary of the information contained in Figure 3C ; it showed that RUNX2 and OPN albumen content of the TDN-treated groups, in the 3-day sample, was 1.21 times and 2.16 times higher than that of control group, the content of the above-mentioned proteins was multiplied by 1.99 and 1.29, respectively, in the 7-day samples. After being exposed to the TDNs for 3 days, OPN and RUNX2 albumens were dyed by immunofluorescence to further verification of the results. We can see that fluorescence intensity of TDN-treated groups was clearly higher than in the control groups ( Figure 3B ). Overall, these results indicated that
TDNs had a positive influence on the up-regulation of osteogenicrelated genes and on the albumen expression of PDLSCs.
| Enhancement of calcium nodule formation and ALP activity
As an early marker of osteogenic differentiation, the ALP activity of PDLSCs treated with TDNs for 7 days was performed in order to evaluate the part played by TDNs on the osteogenic differentiation of PDLSCs. 38 Compared with a blank group, there was a great enhancement of ALP activity and greater NBT formation in the TDNtreated groups ( Figure 4A ).
In addition, calcium nodules, as late indicators of osteogenic differentiation, were detected by Alizarin Red staining to assess the role played by TDNs on PDLSCs. 39 As displayed in Figure 4B , the number of calcium nodules in the experiment group exposed to TDNs for 2 weeks was remarkably higher than that in the blank group without exposure to TDNs ( Figure 4B ). Therefore, these results manifested that TDNs played a significant role in the PDLSCs osteogenic differentiation.
| Mechanism through which TDN regulated the osteogenic differentiation of PDLSCs
The mechanism through which the osteogenic differentiation of PDLSCs was increased by TDNs is still not clear. But some previous studies have demonstrated that the Wnt/β-catenin signalling pathway plays a significant role in the osteogenic differentiation of PDLSCs. [40] [41] [42] Therefore, in order to investigate whether the Wnt/β-catenin signalling pathway might be the potential mechanism through which TDNs facilitate PDLSCs osteogenic differentiation, we performed western blotting (WB) and immunofluorescence staining in order to analyse the protein expression of LEF-1, GSK-3β and β-catenin. Stimulated with TDNs, the WB results displayed that the expression of LEF-1 and β-catenin in the albumen was obviously higher than that in the control group.
Simultaneously, the GSK-3β was expressed in lower quantities in TDN-treated group than in the control groups ( Figure 5B,C) . In order to reconfirm this result, we performed immunofluorescence staining, the results of immunofluorescence staining were consistent with that of WB, that is, TDNs could activate the factors related to the Wnt/β-catenin signalling pathway ( Figure 5A ). Taken together, these results not only verified the previous findings but also provided (Figure 6 ).
As a new three-dimensional structure of DNA nano-biomaterials, TDNs have garnered attention in the field of biomedicine because its structure could be functionalized and designed to respond to the stimulation of the surrounding environment. It could not only be used as a stimulator to adjust biological behaviours such as differentiation, anti-inflammatory response, proliferation and migration of cells, but could also be applied as a biosensor in molecular diagnosis and as a special carrier to transport ligands and drugs such as siRNA, AS1411 aptamers and DOX for molecular and targeted drug delivery. 27, 43, 44 This study explored the effects of TDNs on PDLSCs for the first time, and the results suggested that it could enhance proliferation and promote osteogenesis of PDLSCs. These findings lay a firm foundation for further investigations TDNs and showed their broad application potential in the PDLSC-based nanoengineering. In further studies, we intend to continue investigating the osteogenic differentiation effects of TDNs in animal models and to explored its synthesis with ethylene imine (PEI) to form a PEI/TDNs mixture to delay its degradation and provide sufficient for in vivo investigations. 45 In addition, using TDNs with 3D scaffold materials to reconstruct bone defects or as a special probe to detect associated periodontal pathogens are also interesting research directions for PDLSC-based nanoengineering.
Tetrahedral DNA nanostructure, as a new DNA nanomaterial, was applied in the PDLSC-based nanoengineering system for the first time. The results of this investigation demonstrated that TDNs could play a crucial role in accelerating the proliferation of PDLSCs and had the strongest promotive effect on PDLSCs at a concentration of 250 nmol/L. Simultaneously, the most obvious finding of this study was that the osteogenic differentiation of PDLSCs could be promoted significantly with TDNs by regulating the Wnt/β-catenin pathway. Therefore, TDNs could be a novel nanomaterial that could regulate some cell biological behaviours with a tremendous potential for application in PDLSC-based bone tissue engineering, such as promoting osteogenic differentiation to restore bone defect.
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